





| Salt Composition: | Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg) |
| Manufacturer: | Mankind Pharma Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Glimestar-PM2 Tablet ER is a combination medicine that helps control blood sugar levels in adults with type 2 diabetes mellitus. Glimestar-PM2 Tablet ER is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar levels.
Glimestar-PM2 Tablet ER is a combination of three antidiabetic medicines: Glimepiride, Metformin, and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines, and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimestar-PM2 Tablet ER is to be taken with food.
Alcohol
It is unsafe to consume alcohol with Glimestar-PM2 Tablet ER.
Breastfeed
Glimestar-PM2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Glimestar-PM2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.